NFCR Writer David Perry, Author at NFCR - Page 6 of 9

NFCR Writer David Perry

Pediatric Cancer Drug Has 93 Percent Effectiveness

A new cancer drug, larotrectinib, has in a very early clinical trial been shown to have a 93% (14/15) effectiveness rate for pediatric cancers; that is to say, for not just one cancer, but many. Hailed by the U.S. Food and Drug Administration as a “breakthrough therapy,” larotrectinib targets a…...

Read more

Cloud Atlas

It’s called “the cloud,” but it is not the fluffy white thingees drifting overhead. It promises to revolutionize cancer care. By, of all things, sharing data. “In cancer, only about 4% of patients go on a clinical trial, but that data is not ever really leveraged. The FDA (U.S. Food…...

Read more

Early Days, But New Compound May Prevent Metastasis

Oncologist Dr. Raymond Bergan and his team recently developed a drug compound that, in mouse models, seems to stave off metastasis—cancer spreading....

Read more

The Role of Micronutrients in Battling Cancer

It was largely the work of Helmut Sies, M.D., the esteemed pioneer of oxidative stress whom the National Foundation for Cancer Research (NFCR) supported from 1983 to 2016, that brought the role of micronutrients, including flavonoids, into scientific focus....

Read more

Master Switch Metastasis Agent Identified

In a major breakthrough, scientists led by Elena Deryugina at The Scripps Research Institute (TSRI) identified a specific protein, Latent TGFβ Binding Protein 3—LTBP3 for short—that kicks off a cellular chain reaction resulting in early-development tumors growing new blood vessels. These vessels then act like highways to spread cancer cells…...

Read more

Frederick Alt: It’s Personal

Ask 100 physicians why they got into medicine and you’ll get 100 different answers: Some take the noble route and want to help people, others are just hardwired for it and still others learned early on that potential mates tend to worship doctors (or at least their mothers do!). And…...

Read more

American Flight Attendants at Higher Cancer Risk

New research from Harvard University’s T.H. Chan School of Public Health found that American flight attendants have a higher prevalence of several forms of cancer....

Read more

Web Cavenee: In the Genes

In 2016, archeologists working in the Swartkrans Cave in South Africa found a piece of foot bone belonging to a hominid dating back 1.6 to 1.8 million years. This alone would create a buzz among scientists. But it was what was on the bone that generated headlines: This ancient human…...

Read more

Grant Seeks to Increase Minorities in Cancer Research

In an attempt to bolster the numbers of minorities in cancer research, the Cleveland-based Case Western Reserve University School of Medicine (CaseMed), in partnership with the Case Comprehensive Cancer Center, was awarded a five-year grant, totaling $2.5 million to engage local underrepresented youth....

Read more

Breakthrough in Ewing Sarcoma Research

Ewing sarcoma arises from an error occurring between two genes. This “abnormal fusion transcription factor” causes chaos by turning on genes that should be off, while turning off others that should be on....

Read more